
An Interview With President & CEO Audra Moran
(June 19, 2019) In an interview with SurvivorNet, OCRA President and CEO Audra Moran offers some guidance to women who are battling ovarian cancer: #1 – You don’t need to … Continued
(June 19, 2019) In an interview with SurvivorNet, OCRA President and CEO Audra Moran offers some guidance to women who are battling ovarian cancer: #1 – You don’t need to … Continued
Four multidisciplinary teams to be funded to study survivorship (June 13, 2019) In a new collaboration, the American Cancer Society and Ovarian Cancer Research Alliance have joined forces to fund … Continued
Don’t miss a weekend packed with information and inspiration, July 12-14 in Seattle, Washington! Friday, July 12thWelcome to Seattle! Arrive in early afternoon and catch an optional Seattle Bus Tour, or … Continued
(May 21, 2019) Last night, supporters in NYC packed Carolines on Broadway for Stand Up for Madeline & OCRA, our much-anticipated evening of laughter to end ovarian cancer. Thank you … Continued
(May 21, 2019) Earlier this month, Nature Genetics published a study, in part funded by OCRA, that found 34 genes were connected to women developing the earliest stages of ovarian … Continued
(May 14, 2019) We’re excited to announce that Dr. Mary-Claire King, who identified the germline BRCA1 mutation associated with hereditary breast and ovarian cancer, will be a keynote speaker at … Continued
(May 14, 2019) OCRA received the President’s Award at the first Cancer Community (C2) Awards, created to recognize individuals and organizations who have created positive change in cancer care. The … Continued
(April 3, 2019) We have one week to let the Senate know that we need more funding for ovarian cancer research! Thanks to your efforts, a record 158 U.S. House … Continued
(April 1, 2019) 156 House Members have joined Reps. DeLauro and Duffy in a call for increased ovarian cancer research funding. Reps. Rosa DeLauro (D-CT) and Sean Duffy (R-WI) – … Continued
(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) … Continued
(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill. Together, this passionate group of survivors, caregivers and supporters used … Continued
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through. Deadline is March 25th! … Continued
Get email updates about research news, action alerts, and ways to join the fight.